BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38659068)

  • 1. Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II).
    Soman R; Veeraraghavan B; Hegde A; Varma S; Todi S; Singh RK; Nagavekar V; Rodrigues C; Swaminathan S; Ramsubramanian V; Ansari A; Chaudhry D; Pednekar A; Bhagat S; Patil S; Barkate H
    Expert Rev Anti Infect Ther; 2024 Jun; 22(6):453-468. PubMed ID: 38790080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.
    Tischendorf J; de Avila RA; Safdar N
    Am J Infect Control; 2016 May; 44(5):539-43. PubMed ID: 26899297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy.
    Ma J; Song X; Li M; Yu Z; Cheng W; Yu Z; Zhang W; Zhang Y; Shen A; Sun H; Li L
    Microbiol Res; 2023 Jan; 266():127249. PubMed ID: 36356348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study.
    Zheng G; Cai J; Deng H; Yang H; Xiong W; Chen E; Bai H; He J
    Antimicrob Resist Infect Control; 2024 Apr; 13(1):46. PubMed ID: 38659068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
    Giannella M; Freire M; Rinaldi M; Abdala E; Rubin A; Mularoni A; Gruttadauria S; Grossi P; Shbaklo N; Tandoi F; Ferrarese A; Burra P; Fernandes R; Aranha Camargo LF; Asensio A; Alagna L; Bandera A; Simkins J; Abbo L; Halpern M; Santana Girao E; Valerio M; Muñoz P; Fernandez Yunquera A; Statlender L; Yahav D; Franceschini E; Graziano E; Morelli MC; Cescon M; Viale P; Lewis R;
    Clin Infect Dis; 2021 Aug; 73(4):e955-e966. PubMed ID: 33564840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization.
    Chen X; Wen X; Jiang Z; Yan Q
    Ann Clin Microbiol Antimicrob; 2023 Jan; 22(1):3. PubMed ID: 36627626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Carbapenem-Resistant
    Wangchinda W; Laohasakprasit K; Lerdlamyong K; Thamlikitkul V
    Infect Drug Resist; 2022; 15():2199-2210. PubMed ID: 36312438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Surveillance for Carbapenem-Resistant
    Wangchinda W; Thamlikitkul V; Watcharasuwanseree S; Tangkoskul T
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options.
    Bartal C; Rolston KVI; Nesher L
    Infect Dis Ther; 2022 Apr; 11(2):683-694. PubMed ID: 35175509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models.
    Ramspek CL; Teece L; Snell KIE; Evans M; Riley RD; van Smeden M; van Geloven N; van Diepen M
    Int J Epidemiol; 2022 May; 51(2):615-625. PubMed ID: 34919691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant
    Zhang WX; Chen HY; Chen C; Chen JH; Wan FS; Li LX; Chen M; Zhang J
    Microb Drug Resist; 2021 Oct; 27(10):1312-1318. PubMed ID: 34297609
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting Colonization.
    Rao K; Patel A; Sun Y; Vornhagen J; Motyka J; Collingwood A; Teodorescu A; Baang JH; Zhao L; Kaye KS; Bachman MA
    mSphere; 2021 Jun; 6(3):e0013221. PubMed ID: 34160237
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.